Romond et al developed a cardiac risk score for patients receiving adjuvant chemotherapy for breast cancer. This can be used to estimate the risk of an adverse cardiac event within 5 years. The authros are from multiple hospitals in the United States participating in the National Surgical Adjuvant Breast and Bowel Project.